US-listed Chinese biopharma firm Gracell to raise $150m in Vivo Capital-led PIPE deal

US-listed Chinese biopharma firm Gracell to raise $150m in Vivo Capital-led PIPE deal

Laboratory equipment. Photo: Pixabay

Edited by: Pramod Mathew

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter